Keyword
Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 MEI Pharma Announces Expansion of Phase 1b Study Evaluating Zandelisib and Clinical Pipeline Update
2 MEI Pharma Inc (MEIP) Up 4.09% in Premarket Trading
3 Analyst Rating: Will MEI Pharma Inc (MEIP) Stock Outperform the Market?
4 Do Analysts Agree on MEI Pharma Inc (MEIP) Stock's Target Price?
5 $2.08 Million in Sales Expected for MEI Pharma, Inc. (NASDAQ:MEIP) This Quarter
6 MEI Pharma to Present at Two Upcoming Investor Healthcare Conferences
7 MEI Pharma (MEIP) Reports Expansion of Phase 1b Study Evaluating Zandelisib and Clinical Pipeline Update
8 Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma
9 Why MEI Pharma Is Tanking 15.3% Today
10 MEI Pharma Reports First Quarter Fiscal Year 2021 Results and Operational Highlights
11 MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program
12 MEI PHARMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of MEI Pharma, Inc.
13 MEI Pharma Reports Fiscal Third-Quarter 2020 Results and Recent Corporate Highlights
14 MEI Pharma Announces Fast Track Designation Granted by US FDA for ME-401 For the Treatment of Adult Patients with Relapsed or Refractory Follicular Lymphoma
15 Earnings Release: Here's Why Analysts Cut Their MEI Pharma, Inc. (NASDAQ:MEIP) Price Target To US$9.50
16 MEI Pharma Appoints Brian T. Powl As Senior Vice President, Marketing
17 MEIP Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of MEI Pharma, Inc. and Encourages Investors to Contact the Firm
18 MEIP SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies MEI Pharma, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm
19 MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Are Pretty Bullish On The Stock After Recent Results
20 Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes
21 Growth Investors: Industry Analysts Just Upgraded Their MEI Pharma, Inc. (NASDAQ:MEIP) Revenue Forecasts By 25%
22 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline – MEIP
23 Read This Before Selling MEI Pharma, Inc. (NASDAQ:MEIP) Shares
24 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MEI Pharma, Inc.
25 MEI Pharma and Kyowa Kirin Announces ME-401 Phase 1b Study to be Highlighted in a Presentation at the Virtual Edition of the 25th European Hematology Association Annual Congress
26 Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against MEI Pharma, Inc. (MEIP)
27 Should You Buy MEI Pharma Inc (MEIP) Stock After it Is Up 11.74% in a Week?
28 Portnoy Law: Lawsuit Filed On Behalf of MEI Pharma, Inc. Investors
29 Have Insiders Been Buying MEI Pharma, Inc. (NASDAQ:MEIP) Shares This Year?
30 A Look At MEI Pharma's (NASDAQ:MEIP) CEO Remuneration
31 MEI Pharma: Give It Another Chance
32 MEI Pharma (MEIP) to Report Q4 Earnings: What's in the Cards?
33 Pomerantz Law Firm Announces the Filing of a Class Action against MEI Pharma, Inc. and Certain Officers
34 MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Just Trimmed Their Revenue Forecasts By 0.9%
35 ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds MEI Pharma, Inc. Investors of the Important Deadline in Securities Class Action – MEIP
36 What Is The Ownership Structure Like For MEI Pharma, Inc. (NASDAQ:MEIP)?
37 MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401
38 What Can We Learn About MEI Pharma's (NASDAQ:MEIP) CEO Compensation?
39 Could Mei Pharma Inc (NAQ:MEIP) be a turtle trade?
40 How Many MEI Pharma, Inc. (NASDAQ:MEIP) Shares Do Institutions Own?
41 How Should Investors React To MEI Pharma, Inc.'s (NASDAQ:MEIP) CEO Pay?
42 Analysts Are Upgrading MEI Pharma, Inc. (NASDAQ:MEIP) After Its Latest Results
43 MEIP EQUITY NOTICE: ROSEN, A NATIONAL INVESTOR LAW FIRM, Encourages MEI Pharma, Inc. Investors with Losses to Contact Firm Before Important Deadline in Securities Class Action – MEIP
44 Earnings Update: MEI Pharma, Inc. (NASDAQ:MEIP) Just Reported And Analysts Are Trimming Their Forecasts
45 BRIEF-Helsinn Group And Mei Pharma Discontinue The Phase 3 Study With Pracinostat In Aml After Completing Interim Analysis
46 MEI Pharma and Kyowa Kirin Announce Updated Clinical Data from the Phase 1b Study Evaluating ME-401 on an Intermittent Schedule in Patients with Follicular Lymphoma and Other B-cell Malignancies; Data to be Featured in the American Society of Clinical Oncology 2020 Virtual Scientific Program
47 MEI Pharma Set To Explode With Announcement Of Lucrative Partnership
48 EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against MEI Pharma, Inc. – MEIP
49 Histone Deacetylase 1 Market Global Competition, Size, Business Outlook Market Dynamics 2021 Forecast to 2027 4SC AG, Acetylon Pharmaceuticals, Inc.
50 Will MEI Pharma Inc (MEIP) Beat the Rest of the Stocks in the Healthcare Sector?
51 How MEI Pharma (MEIP) Stock Stands Out in a Strong Industry
52 The MEI Pharma (NASDAQ:MEIP) Share Price Has Gained 41% And Shareholders Are Hoping For More
53 BRIEF-Mei Pharma And Kyowa Kirin Announce Updated Clinical Data From Early-Stage Follicular Lymphoma Study
54 DEADLINE ALERT: Bragar Eagel & Squire, PC Reminds Investors That a Class Action Lawsuit Has Been Filed Against MEI Pharma, Inc. and Encourages Investors to Contact the Firm
55 MEI Pharma Announces Updated Clinical Data from ME-401 Phase 1b Study in Patients with Indolent B-cell Malignancies
56 Bragar Eagel & Squire, PC Reminds Investors That Class Action Lawsuits Have Been Filed Against MEI Pharma, Cabot Oil & Gas, Kodak, and Genius Brands and Encourages Investors to Contact the Firm
57 Constellation Pharma: CPI-0610 Is Well-Differentiated In The Myelofibrosis Treatment Development Pipeline
58 Global Myelodysplastic syndromes (MDS) Market With COVID 19 Impact Analysis| Leading Players In-depth Analysis Research Report Foresight to 2027 – KSU | The Sentinel Newspaper
59 MEI Pharma Presents Updated Clinical Data from the ME-401 Phase 1b study in Patients with Indolent B-cell Malignancies at the 2019 International Conference on Malignant Lymphoma (ICML)
60 BRIEF-Helsinn And MEI Pharma Announce Updated Clinical Data From Phase 2 Study Evaluating Pracinostat In Combination With Azacitidine
61 MEI Pharma (NASDAQ:MEIP) Shareholders Have Enjoyed An Impressive 121% Share Price Gain
62 Is MEIP A Good Stock To Buy Now?
63 MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
64 MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies
65 MEI Pharma: Best-In-Class P13K Delta Inhibitor Makes Significant Progress In The Clinic
66 MEI Pharma Acquires PWT143, A Highly Selective PI3-Kinase Delta Inhibitor
67 Do Directors Own MEI Pharma, Inc. (NASDAQ:MEIP) Shares?
68 San Diego Life Sciences Roundup: MEI Pharma, Turning Point, & More
69 Lifshitz Law Firm, PC Announces Investigation of Cognizant Technology Solutions Corporation, Honeywell International Inc., MEI Pharma, Inc., Nikola Corporation, The Chemours Company and YayYo, Inc.
70 MEI Pharma Announces Topline Data From Phase I Clinical Trial Of Mitochondrial Inhibitor Drug Candidate ME-344
71 Histone Deacetylase 2 Market To Observe Exponential Growth By 2020-2027 | UpMarketResearch – NeighborWebSJ
72 We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely
73 MEIP Stock Forecast, Price & News (MEI Pharma)
74 Nov 18, 2020
75 MEI Pharma Reports Second Quarter Fiscal Year 2017 Results
76 BRIEF-MEI Pharma Announces $75 Mln Private Placement
77 MEI Pharma Announces Closing of Public Offering of Common Stock
78 Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
79 After Strikeout, San Diego's MEI Pharma Looks to Rebuild Confidence
80 Imagine Owning MEI Pharma (NASDAQ:MEIP) And Trying To Stomach The 78% Share Price Drop
81 Meridian Bioscience : Thinking about buying stock in Adaptimmune Therapeutics, MEI Pharma, Dynavax Technologies, AIM ImmunoTech, or Meridian Bioscience?
82 Covid-19 Impact on Histone Deacetylase 2 Market (2020-2026) | Potential growth, attractive valuation make it is a long-term investment | Top Players: 4SC AG, Acetylon Pharmaceuticals Inc., Chipscreen Biosciences Ltd, Curis Inc., GlaxoSmithKline Plc
83 MEIP Price Target, Analyst Ratings and Predictions (MEI Pharma)
84 Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in Blood Advances
85 MEI Pharma Completes Public Offering of Common Stock
86 MEI Pharma (MEIP) Presents At 16th Annual Needham Healthcare Conference
87 Cue Biopharma Welcomes Tamar Howson to its Board of Directors
88 Pre-Open Stock Movers 05/29: (PRTY) (MEIP) (ZS) (BIG) (WSM) (AVEO) (ARVN) (more...)
89 The Week Ahead In Biotech: ASCO Presentations In The Spotlight
90 Non-Hodgkin's Lymphoma (NHL) Therapeutics Clinical Trial Analysis Report 2020
91 VMW, MRVL among premarket gainers
92 Phase 3 Trial of Pracinostat Plus Azacitidine Combination in AML Discontinued
93 Ampio Pharmaceuticals (AMPE) Jumps: Stock Rises 8.7%
94 The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
95 The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs
96 Presage Bio Licenses Anti-Cancer Drug to San Diego's MEI Pharma
97 Estrogen Receptor Beta Market Future Scope including key players Acadia Pharmaceuticals Inc, Karo Pharma AB, Chamaeleo Pharma NV
98 Taiwan economy minister speaks to TSMC about auto chip shortage
99 Epizyme, Inc. Is Doing Everything Right But Its Shares Appear Fairly Priced
100 Actinium Appoints Mary Mei Chen, MD, Ph.D. as Vice President of Clinical Development